As of 2024-07-27, the EV/EBITDA ratio of AngioDynamics Inc (ANGO) is -1.27. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ANGO's latest enterprise value is 230.33 mil USD. ANGO's TTM EBITDA according to its financial statements is -181.99 mil USD. Dividing these 2 quantities gives us the above ANGO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 18.3x | 17.7x |
| Forward P/E multiples | 14.2x - 30.9x | 21.6x |
| Fair Price | (68.90) - (81.07) | (87.39) |
| Upside | -1000.6% - -1159.8% | -1242.4% |
| Date | EV/EBITDA |
| 2024-07-26 | -1.27 |
| 2024-07-25 | -1.23 |
| 2024-07-24 | -1.20 |
| 2024-07-23 | -1.23 |
| 2024-07-22 | -1.15 |
| 2024-07-19 | -1.16 |
| 2024-07-18 | -1.11 |
| 2024-07-17 | -1.21 |
| 2024-07-16 | -1.23 |
| 2024-07-15 | -0.89 |
| 2024-07-12 | -0.90 |
| 2024-07-11 | -0.93 |
| 2024-07-10 | -0.81 |
| 2024-07-09 | -0.82 |
| 2024-07-08 | -0.79 |
| 2024-07-05 | -0.81 |
| 2024-07-03 | -0.83 |
| 2024-07-02 | -0.83 |
| 2024-07-01 | -0.84 |
| 2024-06-28 | -0.91 |
| 2024-06-27 | -0.89 |
| 2024-06-26 | -0.85 |
| 2024-06-25 | -0.83 |
| 2024-06-24 | -0.83 |
| 2024-06-21 | -0.88 |
| 2024-06-20 | -0.88 |
| 2024-06-18 | -0.83 |
| 2024-06-17 | -0.88 |
| 2024-06-14 | -0.94 |
| 2024-06-13 | -0.95 |
| 2024-06-12 | -0.93 |
| 2024-06-11 | -0.99 |
| 2024-06-10 | -1.00 |
| 2024-06-07 | -0.96 |
| 2024-06-06 | -1.02 |
| 2024-06-05 | -1.01 |
| 2024-06-04 | -0.99 |
| 2024-06-03 | -0.99 |
| 2024-05-31 | -0.97 |
| 2024-05-30 | -0.96 |
| 2024-05-29 | -0.93 |
| 2024-05-28 | -0.96 |
| 2024-05-24 | -0.94 |
| 2024-05-23 | -0.93 |
| 2024-05-22 | -0.97 |
| 2024-05-21 | -0.87 |
| 2024-05-20 | -0.86 |
| 2024-05-17 | -0.91 |
| 2024-05-16 | -0.99 |
| 2024-05-15 | -0.98 |